263 related articles for article (PubMed ID: 2429616)
1. Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator.
Peters CJ; Reynolds JA; Slone TW; Jones DE; Stephen EL
Antiviral Res; 1986 Aug; 6(5):285-97. PubMed ID: 2429616
[TBL] [Abstract][Full Text] [Related]
2. Enhanced therapeutic efficacy of poly(ICLC) and ribavirin combinations against Rift Valley fever virus infection in mice.
Kende M; Lupton HW; Rill WL; Levy HB; Canonico PG
Antimicrob Agents Chemother; 1987 Jul; 31(7):986-90. PubMed ID: 3662477
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice.
Kende M
J Biol Response Mod; 1985 Oct; 4(5):503-11. PubMed ID: 2416883
[TBL] [Abstract][Full Text] [Related]
4. Ranking of prophylactic efficacy of poly(ICLC) against Rift Valley fever virus infection in mice by incremental relative risk of death.
Kende M; Lupton HW; Rill WL; Gibbs P; Levy HB; Canonico PG
Antimicrob Agents Chemother; 1987 Aug; 31(8):1194-8. PubMed ID: 3631943
[TBL] [Abstract][Full Text] [Related]
5. A comparison of interferon responses to poly ICLC in males and females.
Bever CT; McFarlin DE; Levy HB
J Interferon Res; 1985; 5(3):423-8. PubMed ID: 2414373
[TBL] [Abstract][Full Text] [Related]
6. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
[TBL] [Abstract][Full Text] [Related]
7. Interferon induction in piglets with polyinosinic:polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose.
Loewen KG; Derbyshire JB
Res Vet Sci; 1988 Jan; 44(1):132-3. PubMed ID: 2453906
[TBL] [Abstract][Full Text] [Related]
8. Tumor response to interferon inducer and radiation effect of serum interferon levels.
Lvovsky EA; D'Souza J; Eng D; D'Souza D; Lvovsky B; Hetland R; Craver WL; Sobel SH
J Biol Regul Homeost Agents; 1988; 2(1):1-6. PubMed ID: 2459908
[TBL] [Abstract][Full Text] [Related]
9. Cortisol induction by poly ICLC: implications for clinical trials of interferon.
Bever CT; McFarland HF; Levy HB; McFarlin DE
Ann Neurol; 1988 Feb; 23(2):196-9. PubMed ID: 2454067
[TBL] [Abstract][Full Text] [Related]
10. The kinetics of interferon induction by poly ICLC in humans.
Bever CT; McFarland HF; McFarlin DE; Levy HB
J Interferon Res; 1988 Aug; 8(4):419-25. PubMed ID: 2459270
[TBL] [Abstract][Full Text] [Related]
11. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
Scharton D; Bailey KW; Vest Z; Westover JB; Kumaki Y; Van Wettere A; Furuta Y; Gowen BB
Antiviral Res; 2014 Apr; 104():84-92. PubMed ID: 24486952
[TBL] [Abstract][Full Text] [Related]
12. Enhanced induction of plasma interferon after subcutaneous administration in rabbits of poly ICLC with albumin.
Pessina GP; Muscettola M; Paulesu L; Bocci V
J Biol Regul Homeost Agents; 1989; 3(3):118-21. PubMed ID: 2483023
[TBL] [Abstract][Full Text] [Related]
13. Phase I-II trials of poly(ICLC) in malignant brain tumor patients.
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
J Interferon Res; 1982; 2(1):1-4. PubMed ID: 6180095
[TBL] [Abstract][Full Text] [Related]
14. Interferon induction by and toxicity of polyriboinosinic acid [poly(rI)].polyribocytidylic acid [poly (rC)], mismatched analog poly (rI).poly[r(C12Uracil)n], and poly(rI).poly(rC) L-lysine complexed with carboxymethylcellulose.
Stringfellow DA; Weed SD
Antimicrob Agents Chemother; 1980 Jun; 17(6):988-92. PubMed ID: 6157363
[TBL] [Abstract][Full Text] [Related]
15. Polyriboinosinic-polyribocytidylic acid-poly-L-lysine complex [poly(ICL)] without carboxymethylcellulose (CMC): a new primate-effective interferon inducer.
Riley FL; Morin ML; Lvovsky E; Stephens EE; Levy HB
Proc Soc Exp Biol Med; 1982 Feb; 169(2):183-8. PubMed ID: 6174989
[No Abstract] [Full Text] [Related]
16. Poly ICLC inhibits Plasmodium cynomolgi B malaria infection in rhesus monkeys.
Puri SK; Dutta GP; Levy HB; Maheshwari RK
J Interferon Cytokine Res; 1996 Jan; 16(1):49-52. PubMed ID: 8640451
[TBL] [Abstract][Full Text] [Related]
17. An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine.
Baer GM; Moore SA; Shaddock JH; Levy HB
Bull World Health Organ; 1979; 57(5):807-13. PubMed ID: 120234
[TBL] [Abstract][Full Text] [Related]
18. Topical treatment of vaccinia virus infection with an interferon inducer in rabbits.
Levy HB; Lvovsky E
J Infect Dis; 1978 Jan; 137(1):78-81. PubMed ID: 624854
[TBL] [Abstract][Full Text] [Related]
19. Killing of Leishmania donovani amastigotes by poly ICLC in hamsters.
Bhakuni V; Singha UK; Dutta GP; Levy HB; Maheshwari RK
J Interferon Cytokine Res; 1996 Apr; 16(4):321-5. PubMed ID: 9162526
[TBL] [Abstract][Full Text] [Related]
20. Interferon induction and therapy of brain tumors in rats by poly(ICLC).
Machida H; Takezawa J; Kuninaka A; Yoshino H; Nakamura O; Takakura K
Microbiol Immunol; 1982; 26(4):353-8. PubMed ID: 6180284
[No Abstract] [Full Text] [Related]
[Next] [New Search]
